新生血管緑内障(Neovascular Glaucoma):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Neovascular Glaucoma Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2530CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年1月21日
◆ページ数:66
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界における新生血管緑内障(Neovascular Glaucoma) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 新生血管緑内障(Neovascular Glaucoma)
  - 当レポートの概要
・新生血管緑内障(Neovascular Glaucoma):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Neovascular Glaucoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Neovascular Glaucoma Global Clinical Trials Review, H1, 2015″ provides data on the Neovascular Glaucoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neovascular Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neovascular Glaucoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Neovascular Glaucoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Neovascular Glaucoma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Neovascular Glaucoma Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Gene Signal International SA 32
Clinical Trial Overview of Gene Signal International SA 32
ODIN Biotech Partners, LLC 33
Clinical Trial Overview of ODIN Biotech Partners, LLC 33
Clinical Trial Overview of Top Institutes / Government 34
Kumamoto University 34
Clinical Trial Overview of Kumamoto University 34
Federal University of Sao Paulo 35
Clinical Trial Overview of Federal University of Sao Paulo 35
University of Illinois 36
Clinical Trial Overview of University of Illinois 36
Shimane University 37
Clinical Trial Overview of Shimane University 37
Universidade Federal de Uberlandia 38
Clinical Trial Overview of Universidade Federal de Uberlandia 38
Hong Kong Eye Hospital 39
Clinical Trial Overview of Hong Kong Eye Hospital 39
University of Lubeck 40
Clinical Trial Overview of University of Lubeck 40
Faculty of Medicine Siriraj Hospital, Mahidol University 41
Clinical Trial Overview of Faculty of Medicine Siriraj Hospital, Mahidol University 41
Shahid Beheshti University of Medical Sciences 42
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 42
Cairo University 43
Clinical Trial Overview of Cairo University 43
Five Key Clinical Profiles 44
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 66

List of Tables
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Neovascular Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Neovascular Glaucoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Neovascular Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Neovascular Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2015* 32
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ODIN Biotech Partners, LLC, 2015* 33
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2015* 34
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 35
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2015* 36
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 37
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal de Uberlandia, 2015* 38
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2015* 39
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Lubeck, 2015* 40
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of Medicine Siriraj Hospital, Mahidol University, 2015* 41
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 42
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cairo University, 2015* 43

List of Figures
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 65

【レポートのキーワード】

新生血管緑内障(Neovascular Glaucoma)、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 新生血管緑内障(Neovascular Glaucoma):世界の治験レビュー(2015年上半期版)(Neovascular Glaucoma Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆